This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

A Clinical Trial Follow-up Study of the Genesis II Posterior Stabilized Total Knee Replacement

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Nova Scotia Health Authority
Information provided by (Responsible Party):
Ross Leighton, Nova Scotia Health Authority
ClinicalTrials.gov Identifier:
NCT00351793
First received: July 12, 2006
Last updated: January 30, 2017
Last verified: January 2017
  Purpose
The purpose of this study is to look at the outcomes of the GENESIS II Posterior Stabilized Total Knee Replacement.

Condition Intervention
Osteoarthritis Device: Knee Implant

Study Type: Observational
Study Design: Observational Model: Case-Control
Time Perspective: Prospective
Official Title: A Clinical Trial Follow-up Study of the Genesis II Posterior Stabilized Total Knee Replacement

Resource links provided by NLM:


Further study details as provided by Ross Leighton, Nova Scotia Health Authority:

Primary Outcome Measures:
  • Effectiveness and Safety [ Time Frame: 5 years ]
    Will evaluate effectiveness and safety during a 5 year period via analysis of the Knee Society Score, revision status, and radiographic evaluation


Secondary Outcome Measures:
  • Knee Society Clinical Rating [ Time Frame: Pre-op, 6 months, 1 year, 2 years, 5 years ]
  • Western Ontario and MacMaster Universities Osteoarthritis Index (WOMAC) [ Time Frame: Pre-op, 6 months, 1 year, 2 years, 5 years ]

Enrollment: 186
Study Start Date: January 2003
Estimated Study Completion Date: December 2018
Estimated Primary Completion Date: December 2018 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Combined Deformity <30 degrees Device: Knee Implant
Total knee replacement with Genesis II posterior stabilized knee
Combined Deformity >30 degrees Device: Knee Implant
Total knee replacement with Genesis II posterior stabilized knee

  Eligibility

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Total knee replacement candidates
Criteria

Inclusion Criteria:

  • A combined deformity of <30 degrees = group 1
  • A combined deformity of >30 degrees = group 2
  • Patient is willing to consent to participate in the study
  • Patient is available for follow-up through at least 2 years but preferably 5 years
  • Patient has met acceptable preoperative medical clearance and is free of or treated for medical conditions that would pose excessive operative risk
  • Patients who are fluent in English and are able to understand their role in a clinical trial

Exclusion Criteria:

  • Active, local infection or systemic infection
  • Fibromyalgia patients
  • Patients whom, as judged by the surgeon, are not capable of understanding the informed consent or the requirements of the protocol and or are reasonably unlikely to be compliant with the prescribed routine and the follow-up evaluation schedule
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00351793

Locations
Canada, Nova Scotia
QEII Health Sciences Centre
Halifax, Nova Scotia, Canada, B3H 3A7
Sponsors and Collaborators
Ross Leighton
Nova Scotia Health Authority
Investigators
Principal Investigator: Ross K Leighton, MD, FRCS(C) Capital Health, Canada
  More Information

Responsible Party: Ross Leighton, Orthopedic Surgeon, Nova Scotia Health Authority
ClinicalTrials.gov Identifier: NCT00351793     History of Changes
Other Study ID Numbers: CDHA-RL-004
Study First Received: July 12, 2006
Last Updated: January 30, 2017

Additional relevant MeSH terms:
Osteoarthritis
Arthritis
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases

ClinicalTrials.gov processed this record on June 28, 2017